Americans are concerned about the high price of drugs.
These unscrupulous industry practices can take many forms, but the result is always the same: Drug prices increase in a captive market.
AdvertisementThat status quo frequently involves pharmaceutical companiesâ€™ making minor changes to existing drugs to gain additional market exclusivity, which keeps prices high.
In the funding bill passed at the end of September, Congress included a portion of the Prescription Drug Pricing Reduction Act (PDPRA) to end this practice.
Americans are demanding relief from high drug prices.